\nNEW FILINGS<\/p>\n
Company: Nurix Therapeutics, Inc.
\nSymbol: NRIX
\nDescription: They are a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Piper Sandler, Stifel
\nCo-Manager: Needham
\nFiled: 7-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Inozyme Pharma, Inc.
\nSymbol: INZY
\nDescription: They are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, Cowen, Piper Sandler
\nCo-Manager: Wedbush PacGrow
\nFiled: 7-2-20
\nListed Cash Raise: $86.25m<\/p>\n
Company: Annexon, Inc.
\nSymbol: ANNX
\nDescription: They are a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, BofA Securities, Cowen
\nFiled: 7-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Vertex, Inc.
\nSymbol: VERX
\nDescription: Vertex delivers comprehensive tax solutions that enable global businesses to transact, comply and grow with confidence.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup, Jefferies
\nCo-Manager: JMP Securities, Stifel, William Blair, CastleOak Securities, L.P.
\nFiled: 07-02-20
\nListed Cash Raise: $100m<\/p>\n
Company: Montrose Environmental Group, Inc.
\nSymbol: MEG
\nDescription: They service complex, recurring and often non-discretionary environmental needs of our diverse clients across our three business segments: Assessment, Permitting and Response; Measurement and Analysis; and Remediation and Reuse.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, William Blair
\nCo-Manager:BNP PARIBAS, Capital One Securities, Stifel, Needham & Company
\nFiled: 6-30-20
\nListed Cash Raise: $160m<\/p>\n
Company: Jamf Holding Corp.
\nSymbol: TBD
\nDescription: They are the standard in Apple Enterprise Management, and our cloud software platform is the only vertically-focused Apple infrastructure and security platform of scale in the world.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, RBC Capital Markets, Mizuho Securities, HSBC
\nCo-Manager: Canaccord Genuity, JMP Securities, Piper Sandler, William Blair, Loop Capital Markets, CastleOak Securities, L.P.
\nFiled: 6-30-20
\nListed Cash Raise: $100m<\/p>\n
Company: ALX Oncology Holdings Inc.
\nSymbol: ALXO
\nDescription: They are a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Credit Suisse, Piper Sandler, Cantor
\nCo-Manager: Life Sciences Advisors
\nFiled: 6-26-20
\nListed Cash Raise: $100m<\/p>\n
Company: Pandion Therapeutics, Inc.
\nSymbol: PAND
\nDescription: They are a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, SVB Leerink, BMO Capital Markets
\nFiled: 6-26-20
\nListed Cash Raise: $75m<\/p>\n
Company: Berkeley Lights, Inc.
\nSymbol: BLI
\nDescription: Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Morgan Stanley, Cowen
\nCo-Manager: William Blair
\nFiled: 6-26-20
\nListed Cash Raise: $100m<\/p>\n
Company: ACell Inc.
\nSymbol: ACLL
\nDescription: They are a leading regenerative medicine company focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): UBS Investment Bank, Barclays, RBC Capital Markets
\nCo-Manager: SunTrust Robinson Humphrey
\nFiled: 6-26-20
\nListed Cash Raise: $86.<\/p>\n
TERMS ADDED<\/strong><\/span><\/p>\n Company: Quhuo Limited Company: BlueCity Holdings Limited Company: Nkarta, Inc.
\nSymbol: QH
\nDescription: They were the largest workforce operational solution platform in China as measured by the number of average monthly active workers in 2019, according to the F&S report. They provide tech-enabled, end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with significant e-commerce exposure, including food delivery, ride-hailing, housekeeping and bike-sharing.
\nShares: 2.7 million ADSs
\nPrice Range: $9.00-$11.00
\nMarket Cap: $461m-$564m
\nTrade Date: Week of July 6
\nUnderwriter(s): Roth Capital Partners, Valuable Capital Limited, Tiger Brokers
\nTerms Added: 6-30-20<\/p>\n
\nSymbol: BLCT
\nDescription: They are the World\u2019s leading LGBTQ platform.
\nShares: 5.3 million ADSs
\nPrice Range: $15.00-$17.00
\nMarket Cap: $534m-$605m
\nTrade Date: Wednesday, July 8
\nUnderwriter(s):AMTD, Loop Capital Markets, Tiger Brokers, Prime Number Capital, R.F. Lafferty
\nTerms Added: 7-1-20<\/p>\n
\nSymbol: NKTX
\nDescription: They are a biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer, or NK, cell therapies to treat cancer.
\nShares: 10 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $370m-$423m
\nTrade Date: Friday, 7\/10
\nUnderwriter(s): Cowen, Evercore, Stifel, Mizuho
\nTerms Added: 7-2-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-13533","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/13533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=13533"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/13533\/revisions"}],"predecessor-version":[{"id":13534,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/13533\/revisions\/13534"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=13533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=13533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=13533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}